New HIV immune training shot shows promise in early trial
NCT ID NCT06430905
First seen Oct 31, 2025 · Last updated May 17, 2026 · Updated 25 times
Summary
This study tested two experimental shots, HB-502 and HB-501, designed to teach the body's immune system to recognize and fight HIV. It involved 30 adults with HIV who were already on stable antiretroviral therapy (ART). The main goal was to check safety and whether the shots could boost the immune response against HIV.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconness Medical Center (BIDMC)
Boston, Massachusetts, 02215, United States
-
Brigham and Women´s Hospital
Boston, Massachusetts, 02115, United States
-
Orlando Immunology Center (OIC)
Orlando, Florida, 32803, United States
-
Perelman Center for Advanced Medicine at the Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
The Hope Clinic at Emory University
Decatur, Georgia, 30030, United States
Conditions
Explore the condition pages connected to this study.